Publications

Microfluidics-assisted fluorescence in situ hybridization for advantageous human epidermal growth factor receptor 2 assessment in breast cancer

Posted on:

Download PDF

Related Articles

Multi-omic spatial profiling reveals the unique virus-driven immune landscape of COVID-19 placentitis

Link

The association between the tumor immune microenvironments and clinical outcome in low-grade, early-stage endometrial cancer patients

Link